Inspiremd Stock Alpha and Beta Analysis
| NSPR Stock | USD 3.00 0.02 0.67% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as InspireMD. It also helps investors analyze the systematic and unsystematic risks associated with investing in InspireMD over a specified time horizon. Remember, high InspireMD's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to InspireMD's market risk premium analysis include:
Beta 0.41 | Alpha 0.24 | Risk 2.92 | Sharpe Ratio 0.0581 | Expected Return 0.17 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
InspireMD |
InspireMD Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. InspireMD market risk premium is the additional return an investor will receive from holding InspireMD long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in InspireMD. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate InspireMD's performance over market.| α | 0.24 | β | 0.41 |
InspireMD expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of InspireMD's Buy-and-hold return. Our buy-and-hold chart shows how InspireMD performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.InspireMD Market Price Analysis
Market price analysis indicators help investors to evaluate how InspireMD stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading InspireMD shares will generate the highest return on investment. By understating and applying InspireMD stock market price indicators, traders can identify InspireMD position entry and exit signals to maximize returns.
InspireMD Return and Market Media
The median price of InspireMD for the period between Mon, Sep 23, 2024 and Sun, Dec 22, 2024 is 2.64 with a coefficient of variation of 8.47. The daily time series for the period is distributed with a sample standard deviation of 0.23, arithmetic mean of 2.69, and mean deviation of 0.19. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Sight Sciences, Inc. Reports Q3 Loss, Misses Revenue Estimates | 11/08/2024 |
2 | What To Expect From InspireMD Inc Q3 2024 Earnings | 11/11/2024 |
3 | InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update | 11/12/2024 |
4 | InspireMD Inc Q3 2024 Earnings Call Highlights Revenue Growth Amid Rising Costs and ... | 11/13/2024 |
5 | StockNews.com Begins Coverage on InspireMD - MarketBeat | 11/18/2024 |
6 | InspireMD Now Covered by Analysts at StockNews.com - MarketBeat | 12/03/2024 |
7 | InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization ... | 12/09/2024 |
8 | InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025 | 12/12/2024 |
About InspireMD Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including InspireMD or other stocks. Alpha measures the amount that position in InspireMD has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 4.19 | 6.15 | 4.68 | 3.75 | Days Of Inventory On Hand | 111.52 | 145.95 | 174.78 | 198.81 |
InspireMD Upcoming Company Events
As portrayed in its financial statements, the presentation of InspireMD's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, InspireMD's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of InspireMD's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of InspireMD. Please utilize our Beneish M Score to check the likelihood of InspireMD's management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with InspireMD
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.